Lipid-lowering drugs: who gets what?

Curr Opin Lipidol. 1998 Aug;9(4):289-94. doi: 10.1097/00041433-199808000-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Cholesterol, LDL / blood
  • Coronary Disease / epidemiology
  • Coronary Disease / prevention & control*
  • Humans
  • Hyperlipoproteinemias / drug therapy
  • Hypertriglyceridemia / drug therapy
  • Hypolipidemic Agents / therapeutic use*
  • Incidence
  • Life Expectancy
  • Lipoproteins, VLDL / blood

Substances

  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Lipoproteins, VLDL